Diagnosis of Duchenne Muscular Dystrophy in a Presymptomatic Infant Using Next-Generation Sequencing and Chromosomal Microarray Analysis: A Case Report
暂无分享,去创建一个
J. Ha | Jin-Hong Shin | Soyoung Lee | Y. Shim | J. Cho | Eun-Woo Park
[1] M. Chang,et al. Dilemmas Within the Korean Health Insurance System , 2020, Journal of preventive medicine and public health = Yebang Uihakhoe chi.
[2] G. Vita,et al. Is it the right time for an infant screening for Duchenne muscular dystrophy? , 2020, Neurological Sciences.
[3] L. Werneck,et al. Duchenne muscular dystrophy: an historical treatment review. , 2019, Arquivos de neuro-psiquiatria.
[4] A. Aartsma-Rus,et al. Therapeutic developments for Duchenne muscular dystrophy , 2019, Nature Reviews Neurology.
[5] G. Lin,et al. Molecular genetic testing and diagnosis strategies for dystrophinopathies in the era of next generation sequencing. , 2019, Clinica chimica acta; international journal of clinical chemistry.
[6] S. Pandya,et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management , 2018, The Lancet Neurology.
[7] M. Mojarrad,et al. Duchenne muscular dystrophy: an updated review of common available therapies , 2018, The International journal of neuroscience.
[8] K. Ormond,et al. National Society of Genetic Counselors Code of Ethics: Explication of 2017 Revisions , 2018, Journal of Genetic Counseling.
[9] The National Society of Genetic Counselors. National Society of Genetic Counselors Code of Ethics , 2018, Journal of Genetic Counseling.
[10] M. Tarnopolsky,et al. Next-Generation Sequencing to Diagnose Muscular Dystrophy, Rhabdomyolysis, and HyperCKemia , 2018, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[11] A. Soylu,et al. Rhabdomyolysis with different etiologies in childhood , 2017, World journal of clinical pediatrics.
[12] Sun Ho Lee,et al. Chromosomal Microarray Testing in 42 Korean Patients with Unexplained Developmental Delay, Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies , 2017, Genomics & informatics.
[13] S. Venance. Approach to the Patient With HyperCKemia , 2016, Continuum.
[14] J. Mendell,et al. Clinical Follow‐Up for Duchenne Muscular Dystrophy Newborn Screening: A Proposal , 2016, Muscle & nerve.
[15] E. Naylor,et al. Twenty‐year follow‐up of newborn screening for patients with muscular dystrophy , 2016, Muscle & nerve.
[16] A. Kornberg,et al. Duchenne muscular dystrophy , 2015, Journal of paediatrics and child health.
[17] J. Holton,et al. Rhabdomyolysis: a genetic perspective , 2015, Orphanet Journal of Rare Diseases.
[18] G. Wolfe,et al. Asymptomatic/pauci‐symptomatic creatine kinase elevations (hyperckemia) , 2013, Muscle & nerve.
[19] J. Westfall,et al. Consider Muscle Disease in Children with Elevated Transaminase , 2012, The Journal of the American Board of Family Medicine.
[20] Cindy Hamil,et al. Evidence‐based path to newborn screening for duchenne muscular dystrophy , 2012, Annals of neurology.
[21] Kevin M Flanigan,et al. The Muscular Dystrophies , 1999, Seminars in Neurology.